Remarkably, ZVI‐NP enhanced antitumor immunity by converting pro‐tumour M2 macrophages into antitumor M1 macrophages, reducing regulatory Tregs, and downregulating CTLA‐4 and PD‐1 in CD8+ T cells, thereby maximising antitumor effects.107. The gene discussed is CD8A; the disease is neoplasm.